BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07178912-completion@plaintrial.com
DTSTAMP:20260928T062845Z
DTSTART;VALUE=DATE:20330930
SUMMARY:Phase II Study of the Combination of Subcutaneous Blinatumomab and 
 Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/
 or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL) — estimated com
 pletion date
DESCRIPTION:Not yet recruiting. Saved on your PlainTrial shortlist. Full tr
 ial record: https://plaintrial.com/trial/NCT07178912
URL:https://plaintrial.com/trial/NCT07178912
END:VEVENT
END:VCALENDAR